Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna (ULL), La Laguna, Spain.
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Eur Respir J. 2023 Dec 21;62(6). doi: 10.1183/13993003.00714-2023. Print 2023 Dec.
The epigenetic mechanisms of asthma remain largely understudied in African Americans and Hispanics/Latinos, two populations disproportionately affected by asthma. We aimed to identify markers, regions and processes with differential patterns of DNA methylation (DNAm) in whole blood by asthma status in ethnically diverse children and youth, and to assess their functional consequences.
DNAm levels were profiled with the Infinium MethylationEPIC or HumanMethylation450 BeadChip arrays among 1226 African Americans or Hispanics/Latinos and assessed for differential methylation per asthma status at the CpG and region (differentially methylated region (DMR)) level. Novel associations were validated in blood and/or nasal epithelium from ethnically diverse children and youth. The functional and biological implications of the markers identified were investigated by combining epigenomics with transcriptomics from study participants.
128 CpGs and 196 DMRs were differentially methylated after multiple testing corrections, including 92.3% and 92.8% novel associations, respectively. 41 CpGs were replicated in other Hispanics/Latinos, prioritising cg17647904 () and cg16412914 () as asthma DNAm markers. Significant DNAm markers were enriched in previous associations for asthma, fractional exhaled nitric oxide, bacterial infections, immune regulation or eosinophilia. Functional annotation highlighted epigenetically regulated gene networks involved in corticosteroid response, host defence and immune regulation. Several implicated genes are targets for approved or experimental drugs, including and . Many differentially methylated loci previously associated with asthma were validated in our study.
We report novel whole-blood DNAm markers for asthma underlying key processes of the disease pathophysiology and confirm the transferability of previous asthma DNAm associations to ethnically diverse populations.
在受哮喘影响不成比例的两个群体——非裔美国人和西班牙裔/拉丁裔中,哮喘的表观遗传机制在很大程度上仍未得到充分研究。我们旨在确定在不同种族的儿童和青少年中,根据哮喘状态在全血中具有不同 DNA 甲基化(DNAm)模式的标志物、区域和过程,并评估其功能后果。
在 1226 名非裔美国人和西班牙裔/拉丁裔中,使用 Infinium MethylationEPIC 或 HumanMethylation450 BeadChip 芯片对 DNAm 水平进行了分析,并根据 CpG 和区域(差异甲基化区域(DMR))水平评估了每个哮喘状态的差异甲基化。在不同种族的儿童和青少年的血液和/或鼻上皮中对新的关联进行了验证。通过将表观基因组学与研究参与者的转录组学相结合,研究了所鉴定的标志物的功能和生物学意义。
在进行多次测试校正后,有 128 个 CpG 和 196 个 DMR 存在差异甲基化,分别包括 92.3%和 92.8%的新关联。在其他西班牙裔/拉丁裔中,有 41 个 CpG 得到了复制,其中 cg17647904()和 cg16412914()被确定为哮喘 DNAm 标志物。具有统计学意义的 DNAm 标志物在哮喘、呼出气一氧化氮分数、细菌感染、免疫调节或嗜酸性粒细胞增多等先前的关联中富集。功能注释突出了涉及皮质类固醇反应、宿主防御和免疫调节的受表观遗传调控的基因网络。一些涉及的基因是已批准或实验性药物的靶点,包括()和()。许多先前与哮喘相关的差异甲基化基因座在我们的研究中得到了验证。
我们报告了哮喘的新型全血 DNAm 标志物,这些标志物与疾病病理生理学的关键过程有关,并证实了先前哮喘 DNAm 关联在不同种族人群中的可转移性。